UPS announced the election of Eva Boratto, Chief Financial Officer and Executive Vice President of CVS Health to the UPS Board of Directors, effective immediately.
“UPS has a robust process in place to identify and add talented leaders who will strengthen our board membership. In Eva, we are adding a seasoned executive with diverse, global perspectives and deep subject matter expertise to support our strategic growth imperatives,” explained David Abney, UPS Executive Chairman.
Boratto, 54, has significant financial and strategic planning expertise. At CVS, she is responsible for all aspects of the company’s financial strategy and operations, including accounting and financial reporting, investor relations, mergers and acquisitions, treasury and capital planning, investments, risk management, tax, budgeting and planning, and procurement. Prior to CVS, Boratto served for 20 years at Merck in executive roles with responsibilities ranging from Reporting and Planning to Controller and Investor Relations. Prior to Merck, she was a Financial Analyst at Bristol-Myers Squibb. Boratto received a Bachelor’s of Science degree from Rutgers University, and an MBA from Drexel University.
“We are thrilled to have Eva joining our Board of Directors,” said UPS Chief Executive Officer Carol Tomé. “She bring a unique set of skills to our board. Further, today’s appointment is a meaningful move in support of our commitment to diversity and inclusion.”
Boratto will join the Board’s Audit Committee.
